original ) (raw )Guidelines for development of diagnostic markers in bladder cancer
Peter Goebell
World Journal of Urology, 2008
View PDFchevron_right
Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder Lesions
Kiril Trpkov
The American Journal of Surgical Pathology, 2014
View PDFchevron_right
The clinical relevance of urine-based markers for diagnosis of bladder cancer
amr amin
Medical Oncology, 2011
View PDFchevron_right
Comparison of Urinary Cytology and Fluorescence-In-Situ Hybridisation Assay (Fish) for the Detection of Urothelial Bladder Carcinoma
teresa mchale
European Urology Supplements, 2006
View PDFchevron_right
Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry
Alfred Böcking
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology, 2001
View PDFchevron_right
Detection of bladder tumors by immunostaininc of the lewis x antigen in cells from voided urine
Amos Shapiro
Urology, 1995
View PDFchevron_right
Novel aspects of clinical and pathological prognostic markers of urinary bladder and kidney cancers
János Révész
View PDFchevron_right
Polyclonal antibody from 47 kDa protein of bladder cancer is sensitive and specific for detection of bladder cancer
Basuki Purnomo
Biomarkers and Genomic Medicine, 2014
View PDFchevron_right
Carcinoma of the Bladder: A Case Report
Antonio Manzelli
2013
View PDFchevron_right
Characteristics of prostate cancers found in specimens removed by radical cystoprostatectomy for bladder cancer and their relationship with serum prostate-specific antigen level
Tohru Nakagawa
Cancer Science, 2009
View PDFchevron_right
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer
Giovanni Casetta
Clinica Chimica Acta, 2001
View PDFchevron_right
Blood group antigens in the normal and neoplastic bladder epithelium
T. Feizi
Journal of Clinical Pathology, 1983
View PDFchevron_right
Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?
Benjamin Nisman
Expert Review of Anticancer Therapy, 2010
View PDFchevron_right
Urinary Markers in Bladder Cancer: An Update
Maria Morelli
Frontiers in Oncology, 2018
View PDFchevron_right
Detection of bladder cancer from the urine using fluorescencein situ hybridization technique
Attila Szendroi
Pathology & Oncology …, 2007
View PDFchevron_right
Cellular heterogeneity in a tissue culture cell line derived from a human bladder carcinoma
Ros Hastings
British Journal of Cancer, 1983
View PDFchevron_right
Urinary Cytology in the Diagnosis of Bladder Cancer
Shadab Rangrez
2021
View PDFchevron_right
Expression of the tumour-associated antigen CA-242 in transitional cell bladder tumours: a comparison with CA-50
M. Eskelinen
European Journal of Cancer, 1993
View PDFchevron_right
Flow cytometry: Role in monitoring transitional cell carcinoma of bladder
Carl Olsson
Urology, 1986
View PDFchevron_right
Secondary neoplasms of the urinary bladder-clinical management and oncological outcomes
Farhan Malik
Translational Andrology and Urology, 2021
View PDFchevron_right
Cytologic Evaluation of Low Grade Transitional Cell Carcinoma and Instrument Artifact in Bladder Washings
Jun-Kyu Suh
Acta Cytologica, 2002
View PDFchevron_right
Comparative Predictive Values of Urinary Cytology, Urinary Bladder Cancer Antigen, Cyfra 21-1 and NMP22 for Evaluating Symptomatic Patients at Risk for Bladder Cancer
Marta Sanchez-carbayo
The Journal of Urology, 2001
View PDFchevron_right
Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma
Manuel Urrutia
Cancer, 2001
View PDFchevron_right
Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer
Andrew Lightfoot
International Journal of Urology, 2012
View PDFchevron_right
Non Urothelial Bladder Cancers: A Case Series
tarun kumar
Indian Journal of Surgical Oncology, 2012
View PDFchevron_right
IMMUNOSTAINING OF LEWIS X IN CELLS FROM VOIDED URINE, CYTOPATHOLOGY AND ULTRASOUND FOR NONINVASIVE DETECTION OF BLADDER TUMORS
Amos Shapiro
The Journal of Urology, 1998
View PDFchevron_right
Urinary Bladder Cancer Susceptibility Markers. What Do We Know about Functional Mechanisms?
Gerald Verhaegh
International Journal of Molecular Sciences, 2013
View PDFchevron_right
Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses
Eric Wespes
Cytopathology, 2007
View PDFchevron_right
Liquid biopsies in urological cancers: what we need to know before starting using them
Francesca Giunchi
Expert Review of Molecular Diagnostics, 2019
View PDFchevron_right
Muscle-invasive bladder cancer
Adam Landau
2014
View PDFchevron_right
Prognostic markers in low-grade papillary urothelial neoplasms of the urinary bladder
David Ramos
Current Diagnostic Pathology, 2005
View PDFchevron_right
Distribution of 486P 3/12 Antigen, Abo(H) Blood Group Antigen and T Antigen in Cystectomy Specimens from Patients with Stage T2 Transitional Cell Carcinoma of the Bladder
Edith Huland
The Journal of Urology, 1992
View PDFchevron_right
Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples
Silvia Brunelli
Cancer Science, 2010
View PDFchevron_right
Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer
Abdullah Alghamdi
Urology Annals, 2014
View PDFchevron_right
Prognostic value of static cytometry in transitional cell carcinoma of the bladder: Recurrence rate and survival in a group of patients at 10 years follow-up
Tommaso Cai
Oncology Reports, 2006
View PDFchevron_right